SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-16-001282
Filing Date
2016-04-13
Accepted
2016-04-13 08:00:38
Documents
4
Period of Report
2016-04-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 VALEANT PHARMACEUTICALS FORM 8-K form8k.htm 8-K 33376
2 PRESS RELEASE ex99_1.htm EX-99.1 14585
3 logo_s.jpg GRAPHIC 5303
4 logo_l.jpg GRAPHIC 13033
  Complete submission text file 0001341004-16-001282.txt   74763
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161568392
SIC: 2834 Pharmaceutical Preparations